Abhimanyu Ojha

Experience

• 

  Ranbaxy

  Jun 2003 - Jul 2009

  Driving Pharma Value Chain projects, Strategic Initiatives and supporting corporate decisions.Also handled Strategic Business Planning and Global Operations Review.Key outcomes Contributed to the strategic shift of focus across the organization from Developed to Emerging markets. Profile: Financial Planning, MIS, Expense Mgmt, Product Costing & Analytical support for decision- making.Key outcomes: Led a cross functional team for improvement in product costings to strengthen overall profitability of the business.

  • Executive Assistant to CEO & MD

    Jan 2005 - Jul 2009

  • Manager Business Finance – India Business

    Jun 2003 - Dec 2004
• 

  Ranbaxy, Romania

  Jul 2009 - Dec 2010

  Deputy Director Finance

  Incharge of Management Finance for Marketing, Manufacturing & R&D Operations for Ranbaxy Terapia, Romania. Handling Financial Planning, MIS, Business partnering, Balance sheet strengthening & Performance analytics.Key outcomes: Implemented action plans to strengthen balance sheet through business restructuring. Initiated factoring of receivables to strengthen cash flow and curtail overall level of commercial risk.

• 

  Ranbaxy

  Dec 2010 - Jan 2015

  Profile - Global Financial Reporting & Analysis, Strategic Financial Planning, Performance measurement and reporting, Inter-entity transfer pricing and Corporate Controller.Key Outcomes: Identified and drove the implementation of sustainable profitability improvement in the company P/L 2012 thru 2015. Designed and implemented a new performance assessment framework for each business and function that essentially enhanced linkage to specific deliverables and accountability. Presented critical assessment of negative ROI operations that led to restructuring of several business operations. Show less Handing Strategy for Collaboration & Integration betweeen Daiichi Sankyo (Japan) and RanbaxyProfile: Project Lead in Global Hybrid business team (Ranbaxy and Daiichi Sankyo (DS) – Global level synergy & collaboration projects being driven by a cross functional team .Reporting: Steering committee comprising of a Member of the DS Board and CEO & MD Ranbaxy. Key Outcomes: Implemented Hybrid model in key markets unleashing operational synergies leading to increase in market share and profitability. Show less

  • Head- Global Business Finance

    Mar 2012 - Jan 2015

  • General Manager - Strategy, Global Hybrid Business

    Dec 2010 - Mar 2012
• 

  SUN PHARMA

  Feb 2015 - Dec 2015

  Head- Corporate Business Finance

  Profile – To lead the Corporate FP&A function for the organization after the acquisition of Ranbaxy. The focus was on setting up a globally integrated Financial Planning and Reporting Process for the new organization. Also, Integration synergies reporting, Performance measurement and reporting, Inter-entity transfer pricing and Corporate expense controller.Key Outcomes: Set up and ran the budgeting process for the consolidated organization post-acquisition of Ranbaxy. Developed and implemented the complete management reporting and performance analysis framework for the consolidated organization. Operationalised Integration & synergies assessment and reporting framework for the consolidated organization in partnership with Mckinsey. Show less

• 

  Mylan

  Jan 2016 - Dec 2020

  Head Commercial Finance, India & Emerging Markets

  Profile: Providing Leadership to the Commercial finance organization for the business spread across India and Emerging Markets (Asia, Africa and Latam). Partnering with the Business to drive the Strategic/long-term objectives as well as focus on the priorities for near-term performance. Currently business size is in excess of US $ 1.5 Billion, with a significant local presence in multiple markets (both commercial and manufacturing operations) in each geography. Functionally the team is responsible for accounting, statutory and management reporting, local taxation & treasury, FP&A and business partnering and commercial decision making.Key Outcomes: Structured and developed the commercial finance organization. Ingrained the philosophy of true business partnering and joint responsibility for performance targets. Strengthened risks & governance framework across the region. Successfully led the integration of a large business acquisition across South East Asia. Led entity restructuring and consolidation exercise to optimize the entity and capital structures across the organization. Entity transfer pricing for new entities. Setting up new commercial models optimizing transactional cost and tax considerations. Close partnership with business head to sustain performance through timely anticipation of risks and opportunities. Also, closely collaborating to develop and drive the strategic direction of the overall business. Show less

• 

  Viatris

  Jan 2021 - Sept 2024

  Global Head, Office of Business Performance & Management

  Profile: Responsible for monitoring and driving business performance for the organization globally (USD 15 Bn). Setting standards for Operational parameters and identifying the short- and medium-term risks and mitigation plans for the business. In alignment with organizational priorities, developing strategic alternatives and executing projects to further the value creation in line with the corporate objectives.Key Outcomes:Set up 1st 5 year strategic & financial plan for Viatris with timelines for strategic pivots to unleash growth drivers. Partnered with Business Development to identify and execute divestments of mature businesses to create elbow room to invest in long term growth assets. Drove business execution in partnership with commercial organization to deliver targets consistently over past 12 quarters. Sharpened returns on commercial SGA by implementing & monitoring through a growth responsiveness framework Show less

• 

  Intas Pharmaceuticals

  Jul 2024 - now

  President Global Finance & CFO